SUVALENT THERAPEUTICS INC.
Biotech · Private
Small molecule SUMO E1 inhibitors for targeted cancer therapy
- Grants
- $4.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 3 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | $788,879 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | $1,997,648 | |
| Federal grant | Department of Health and Human Services · Phase II · Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | $1,208,769 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an oral drug targeting SUMOylation | $232,759 | |
| Federal grant | Department of Health and Human Services · Phase I · Orally available allosteric inhibitor of protein sumoylation | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1796 | NATSAR PHARMACEUTICALS, INC. | — | $4.2M |
| 1797 | vTv Therapeutics Holdings LLC | — | — |
| 1798 | Arbor Plastic Technologies, LLC | — | $910K |
| 1799 | SUVALENT THERAPEUTICS INC. | — | — |
| 1800 | AZYP, LLC | — | — |
| 1801 | MEDIUM ENTERTAINMENT INC | — | $1.0M |
| 1802 | Correlate Infrastructure Partners, Inc. | — | $3.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Nitrile Sumo Inhibitors And Uses Thereofgranted
- Sumo Inhibitor Compounds And Uses Thereofgranted
- Sumo Inhibitor Compounds And Uses Thereofgranted
- Combination Therapy For Treatment Of Cancerapplication
- Nitrile Sumo Inhibitors And Uses Thereofapplication
- 5,6-DIHYDRO-4H-THIENO[2,3-C]PYRROLE Sumo Inhibitors And Uses Thereofapplication
- Nitrile Sumo Inhibitors And Uses Thereofapplication
- 4,5,6,7-TETRAHYDROTHIENO[2,3-CJPYRIDINE Sumo Inhibitors And Uses Thereofapplication
- Combination Therapy For Treatment Of Cancerapplication
- 5,6-DIHYDRO-4H-THIENO[2,3-C]PYRROLE Sumo Inhibitors And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.